US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
IL119660A
(en)
|
1993-05-10 |
2002-09-12 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5773025A
(en)
*
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
EP0647448A1
(de)
*
|
1993-10-07 |
1995-04-12 |
Euroceltique S.A. |
Oral verabreichbare, Opioid-Analgetika enthaltende Arzneimittel mit verlängerter Wirkung
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US20020006438A1
(en)
*
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
US5965161A
(en)
*
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5871776A
(en)
*
|
1995-01-31 |
1999-02-16 |
Mehta; Atul M. |
Controlled-release nifedipine
|
ATE212544T1
(de)
*
|
1995-06-09 |
2002-02-15 |
Scherer Technologies Inc R P |
Weichgelatinekapsel mit teilchenmaterial
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
US5733578A
(en)
*
|
1995-11-15 |
1998-03-31 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
US5939356A
(en)
*
|
1996-06-21 |
1999-08-17 |
Southwest Research Institute |
Controlled release coated agricultural products
|
US6238704B1
(en)
*
|
1996-09-13 |
2001-05-29 |
Shionogi & Co., Ltd. |
Sustained-release preparation utilizing thermal change and process for the production thereof
|
US5807580A
(en)
*
|
1996-10-30 |
1998-09-15 |
Mcneil-Ppc, Inc. |
Film coated tablet compositions having enhanced disintegration characteristics
|
US6180128B1
(en)
*
|
1997-01-27 |
2001-01-30 |
C-Cure Corp. |
Non-carcinogenic substitute for play sand
|
ATE322892T1
(de)
|
1997-07-02 |
2006-04-15 |
Euro Celtique Sa |
Stabilisierte tramadol formulierungen mit verzögerter freisetzung
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
EP1028820B1
(de)
*
|
1997-10-15 |
2009-12-30 |
University Of South Florida |
Beschichtung von partikelmaterial mittels superkritischer flüssigkeit
|
US8679534B2
(en)
*
|
1997-12-12 |
2014-03-25 |
Andrx Labs, Llc |
HMG-CoA reductase inhibitor extended release formulation
|
US6485748B1
(en)
*
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
KR100417489B1
(ko)
|
1997-12-22 |
2004-02-05 |
유로-셀티크 소시에떼 아노뉨 |
오피오이드 효능제/길항제 혼합물
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
US6245357B1
(en)
*
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US5976507A
(en)
*
|
1998-06-04 |
1999-11-02 |
Colgate Palmolive Company |
Dentrifice composition containing encapsulated reactive ingredients
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
DE19901686A1
(de)
*
|
1999-01-18 |
2000-07-20 |
Gruenenthal Gmbh |
Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6432448B1
(en)
*
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
CN101288663A
(zh)
*
|
1999-09-14 |
2008-10-22 |
史密丝克莱恩比彻姆公司 |
制备水性包被小球粒的方法
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
HU230828B1
(en)
|
1999-10-29 |
2018-08-28 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
IL151058A0
(en)
|
2000-02-08 |
2003-04-10 |
Euro Celtique Sa |
Controlled-release compositions containing opioid agonist and antagonist
|
DK1299104T3
(da)
|
2000-02-08 |
2009-08-03 |
Euro Celtique Sa |
Orale opioidagonistformuleringer sikret mod forfalskning
|
GB0007419D0
(en)
†
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
SE0001151D0
(sv)
*
|
2000-03-31 |
2000-03-31 |
Amarin Dev Ab |
Method for producing a controlled-release composition
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
US6663686B1
(en)
|
2000-06-27 |
2003-12-16 |
Agrium, Inc. |
Controlled release fertilizer and method for production thereof
|
WO2002036099A1
(en)
|
2000-10-30 |
2002-05-10 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
BR0115585A
(pt)
|
2000-11-28 |
2005-12-13 |
Fmc Corp |
Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
|
US6486248B2
(en)
|
2001-01-08 |
2002-11-26 |
Milliken & Company |
Liquid colorant and method
|
US6878309B2
(en)
*
|
2001-02-12 |
2005-04-12 |
Dober Chemical Corp. |
Controlled release cooling additive composition
|
US6946146B2
(en)
*
|
2001-04-18 |
2005-09-20 |
Nostrum Pharmaceuticals Inc. |
Coating for a sustained release pharmaceutical composition
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US20030065002A1
(en)
|
2001-05-11 |
2003-04-03 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant controlled-release opioid dosage form
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US7052706B2
(en)
*
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
JP4256259B2
(ja)
|
2001-07-18 |
2009-04-22 |
ユーロ−セルティーク エス.エイ. |
オキシコドン及びナロキソンの医薬配合物
|
AU2002323032B2
(en)
|
2001-08-06 |
2005-02-24 |
Euro-Celtique S.A. |
Opioid agonist formulations with releasable and sequestered antagonist
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030157168A1
(en)
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
EP1429728A1
(de)
*
|
2001-08-29 |
2004-06-23 |
SRL Technologies, Inc. |
Zubereitungen mit verzögerter freisetzung
|
JP4925526B2
(ja)
*
|
2001-09-10 |
2012-04-25 |
旭化成ケミカルズ株式会社 |
薬物の混合方法
|
AR036797A1
(es)
|
2001-10-15 |
2004-10-06 |
Ferring Bv |
Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
|
IL146462A
(en)
|
2001-11-13 |
2015-02-26 |
Lycored Bio Ltd |
Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
|
FR2832632B1
(fr)
|
2001-11-26 |
2004-04-23 |
Mane Fils V |
Capsule a solubilisation et liberation du contenu rapides
|
US20030118647A1
(en)
*
|
2001-12-04 |
2003-06-26 |
Pawan Seth |
Extended release tablet of metformin
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US20050025791A1
(en)
|
2002-06-21 |
2005-02-03 |
Julius Remenar |
Pharmaceutical compositions with improved dissolution
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
EP1494998A2
(de)
|
2002-03-01 |
2005-01-12 |
University Of South Florida |
Mehrkomponenten festphasen enthaltend wenigstens einen pharmazeutischen wirkstoff
|
CA2708900C
(en)
|
2002-04-05 |
2019-06-04 |
Purdue Pharma |
Pharmaceutical preparation containing oxycodone and naloxone
|
US6958161B2
(en)
*
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
US20070196481A1
(en)
*
|
2002-07-25 |
2007-08-23 |
Amidon Gregory E |
Sustained-release tablet composition
|
PE20040134A1
(es)
*
|
2002-07-25 |
2004-03-06 |
Pharmacia Corp |
Forma de dosificacion de una vez al dia de pramipexol
|
US20050226926A1
(en)
*
|
2002-07-25 |
2005-10-13 |
Pfizer Inc |
Sustained-release tablet composition of pramipexole
|
CA2488860A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Pharmacia Corporation |
Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
|
US20040016276A1
(en)
*
|
2002-07-26 |
2004-01-29 |
Wynnyk Nick P. |
Controlled release fertilizer having improved mechanical handling durability and method for production thereof
|
ES2358151T3
(es)
|
2002-08-15 |
2011-05-06 |
Euro-Celtique S.A. |
Composiciones farmacéuticas que comprenden un antagonista opioide.
|
US20040043064A1
(en)
*
|
2002-08-29 |
2004-03-04 |
Iorio Theodore L. |
Dosage forms having reduced moisture transmission
|
AU2003270778B2
(en)
|
2002-09-20 |
2009-10-08 |
Alpharma Pharmaceuticals, Llc |
Sequestering subunit and related compositions and methods
|
US20060052432A1
(en)
*
|
2002-09-20 |
2006-03-09 |
Julius Remenar |
Pharmaceutical compositions with improved dissolution
|
ES2206047B1
(es)
*
|
2002-10-22 |
2005-08-01 |
Universidad De Granada |
Sintesis de un transportador de morfina para formas farmaceuticas liquidas orales de accion controlada.
|
WO2004047752A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations of celcoxib
|
JP4865330B2
(ja)
|
2002-12-13 |
2012-02-01 |
デュレクト コーポレーション |
経口ドラッグデリバリーシステム
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
EP2339328A3
(de)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
JP5501553B2
(ja)
|
2003-04-21 |
2014-05-21 |
ユーロ−セルティーク エス.エイ. |
同時押出逆作用剤粒子を含有する改変防止剤形およびその製造工程
|
WO2004093883A2
(en)
|
2003-04-23 |
2004-11-04 |
Ferring B.V. |
Sachet for a pharmaceutical composition
|
GB2402679A
(en)
*
|
2003-06-10 |
2004-12-15 |
Reckitt Benckiser Nv |
Automatic washing machine detergent dispensing device
|
US7632521B2
(en)
*
|
2003-07-15 |
2009-12-15 |
Eurand, Inc. |
Controlled release potassium chloride tablets
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
US20050147663A1
(en)
*
|
2003-07-17 |
2005-07-07 |
Mohan Mailatur S. |
Method of treatment for improved bioavailability
|
FR2859729B1
(fr)
*
|
2003-09-12 |
2006-02-24 |
Roquette Freres |
Dispersions aqueuses d'au moins un polymere biodegradable
|
EP2298303A1
(de)
|
2003-09-25 |
2011-03-23 |
Euro-Celtique S.A. |
Pharmazeutische kombinationen von hydrocodon und naltrexon
|
US20070269505A1
(en)
*
|
2003-12-09 |
2007-11-22 |
Flath Robert P |
Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same
|
US8883204B2
(en)
|
2003-12-09 |
2014-11-11 |
Purdue Pharma L.P. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
EP2343073A3
(de)
|
2003-12-11 |
2011-10-12 |
Sepracor Inc. |
Kombination eines Beruhigungsmittels und eines Neurotransmittermodulators und Verfahren zur Verbesserung der Schlafqualität und Behandlung von Depressionen
|
EP1547601A1
(de)
*
|
2003-12-23 |
2005-06-29 |
Ferring B.V. |
Beschichtungsverfahren
|
TW201509943A
(zh)
|
2004-03-30 |
2015-03-16 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
DE602005012244D1
(de)
*
|
2004-03-30 |
2009-02-26 |
Euro Celtique Sa |
Manipulationssichere dosierform mit einem adsorbens und einem adversen mittel
|
EP1604666A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
|
EP1604667A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung des Restless Leg Syndroms
|
PT1765292T
(pt)
|
2004-06-12 |
2017-12-29 |
Collegium Pharmaceutical Inc |
Formulações de fármacos dissuasoras de abuso
|
KR20130003040A
(ko)
*
|
2004-08-13 |
2013-01-08 |
베링거 인겔하임 인터내셔날 게엠베하 |
프라미펙솔 또는 약제학적으로 허용되는 이의 염을 포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의 용도
|
DK1781260T4
(da)
*
|
2004-08-13 |
2014-06-23 |
Boehringer Ingelheim Int |
Tabletformulering med forlænget frigivelse indeholdende pramipexol eller et farmaceutisk acceptabelt salt deraf, fremgangsmåde til fremstilling deraf og anvendelse deraf
|
BRPI0515600A
(pt)
*
|
2004-09-01 |
2008-07-29 |
Euro Celtique Sa |
formas farmacêuticas opióides tendo cmédia e auc em estado estável proporcionais à dose e cmax de dose única inferior ao proporcional à dose
|
US20060093629A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
GB0427455D0
(en)
*
|
2004-12-15 |
2005-01-19 |
Jagotec Ag |
Dosage forms
|
JP5739080B2
(ja)
*
|
2005-01-27 |
2015-06-24 |
アレムビック・リミテッドAlembic Limited |
レベチラセタムの徐放性製剤
|
EP2319499A1
(de)
*
|
2005-01-28 |
2011-05-11 |
Euro-Celtique S.A. |
Alkoholresistente Arzneiformen
|
EP1695700A1
(de)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Darreichungsform enthaltend Oxycodon und Naloxon
|
EP1702558A1
(de)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Verfahren und Vorrichtung zur Darmtätigkeitserfassung
|
EP1754471A1
(de)
|
2005-08-18 |
2007-02-21 |
ORAMON-Arzneimittel GmbH & Co. KG |
Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
|
EP1813276A1
(de)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Manipulationssichere Dosierformen
|
DK3095447T3
(da)
|
2006-02-03 |
2022-01-31 |
Opko Renal Llc |
Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
|
WO2007092718A2
(en)
*
|
2006-02-07 |
2007-08-16 |
Fmc Corporation |
Coating process to produce controlled release coatings
|
WO2007090883A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Boehringer Ingelheim International Gmbh |
Extended release formulation
|
CA2641665A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Boehringer Ingelheim International Gmbh |
Modified release formulation
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
FR2897267A1
(fr)
*
|
2006-02-16 |
2007-08-17 |
Flamel Technologies Sa |
Formes pharmaceutiques multimicroparticulaires pour administration per os
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
MX2008016372A
(es)
|
2006-06-19 |
2009-05-28 |
Alpharma Inc |
Composiciones farmaceuticas.
|
EP3659608A1
(de)
|
2006-06-21 |
2020-06-03 |
Opko Ireland Global Holdings, Ltd. |
Therapie unter verwendung von vitamin-d-sättigungsmittel und vitamin-d-hormonersatzmittel
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
WO2008083709A1
(en)
*
|
2007-01-10 |
2008-07-17 |
Bayer Cropscience Ag |
Insecticidal fertilizer mixtures
|
US7879747B2
(en)
|
2007-03-30 |
2011-02-01 |
Kimberly-Clark Worldwide, Inc. |
Elastic laminates having fragrance releasing properties and methods of making the same
|
CN104257667B
(zh)
|
2007-04-25 |
2019-06-04 |
欧普科Ip 控股Ii 有限公司 |
治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
|
EP2481400B1
(de)
|
2007-04-25 |
2014-06-18 |
Cytochroma Inc. |
Orale Zusammensetzungen mit kontrollierter Freisetzung mit einer Vitamin-D-Verbindung und einem wachsartigen Träger
|
US20100144684A1
(en)
|
2007-04-25 |
2010-06-10 |
Proventiv Therapeutics, Inc. |
Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
|
US8007707B1
(en)
|
2007-05-15 |
2011-08-30 |
Fresh Products, Inc. |
Method of manufacture air freshening article
|
WO2009042114A2
(en)
|
2007-09-21 |
2009-04-02 |
The Johns Hopkins University |
Phenazine derivatives and uses thereof
|
ES2337935T3
(es)
*
|
2007-11-09 |
2010-04-30 |
Acino Pharma Ag |
Comprimidos de accion retardada con hidromorfona.
|
WO2009088414A2
(en)
|
2007-12-06 |
2009-07-16 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
US8404260B2
(en)
|
2008-04-02 |
2013-03-26 |
Bayer Cropscience Lp |
Synergistic pesticide compositions
|
WO2009124210A1
(en)
|
2008-04-02 |
2009-10-08 |
Cytochroma Inc. |
Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
|
DE102008021473A1
(de)
*
|
2008-04-29 |
2009-11-12 |
Heraeus Kulzer Gmbh |
Mit Antiplaque-Wirkstoff(en) ausgestattete Dentalmaterialien
|
US7883638B2
(en)
|
2008-05-27 |
2011-02-08 |
Dober Chemical Corporation |
Controlled release cooling additive compositions
|
US20100003322A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Lai Felix S |
Enteric coated hydrophobic matrix formulation
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
KR20110075011A
(ko)
*
|
2008-11-10 |
2011-07-05 |
(주)아모레퍼시픽 |
서방성 미립자 및 이의 제조방법
|
US20120065221A1
(en)
*
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
PT2405915T
(pt)
|
2009-03-10 |
2019-01-29 |
Euro Celtique Sa |
Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
CN103037902A
(zh)
|
2010-03-29 |
2013-04-10 |
赛特克罗公司 |
用于降低甲状旁腺水平的方法和组合物
|
US20120090366A1
(en)
|
2010-04-16 |
2012-04-19 |
Taylor Pursell |
Controlled release fertilizer with biopolymer coating and process for making same
|
CA2798702A1
(en)
|
2010-05-11 |
2011-11-17 |
Cima Labs Inc. |
Alcoholresistant metoprolol-containing extended-release oral dosage forms
|
CN107669687A
(zh)
|
2010-09-01 |
2018-02-09 |
艾尼纳制药公司 |
用于体重控制的5‑ht2c激动剂的调节释放剂型
|
SG191288A1
(en)
|
2010-12-22 |
2013-07-31 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
ES2581323T3
(es)
|
2010-12-23 |
2016-09-05 |
Purdue Pharma Lp |
Formas de dosificación oral sólida resistentes a alteraciones
|
CA2837077A1
(en)
*
|
2011-06-01 |
2012-12-06 |
Fmc Corporation |
Controlled release solid dose forms
|
US9243394B2
(en)
|
2011-09-20 |
2016-01-26 |
Fresh Products, Inc. |
Replaceable restroom urinal assemblies, including urinal screens
|
BR112014007902A2
(pt)
*
|
2011-10-06 |
2017-04-18 |
Novartis Ag |
composições farmacêuticas compreendendo 40-o-(2-hidróxi)etil-rapamicina
|
US9566241B2
(en)
|
2012-02-21 |
2017-02-14 |
Auburn University |
Buprenorphine nanoparticle composition and methods thereof
|
AR092820A1
(es)
|
2012-04-17 |
2015-05-06 |
Purdue Pharma Lp |
Sistemas y metodos para tratar una respuesta farmacodinamica adversa inducida por opioides, unidad de dosis, kit
|
PL2872121T3
(pl)
|
2012-07-12 |
2019-02-28 |
SpecGx LLC |
Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
|
WO2014013311A1
(en)
|
2012-07-16 |
2014-01-23 |
Rhodes Technologies |
Process for improved opioid synthesis
|
KR101946103B1
(ko)
|
2012-07-16 |
2019-02-08 |
로드스 테크놀로지즈 |
개선된 오피오이드 합성을 위한 방법
|
US9149533B2
(en)
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
EP2983468A4
(de)
|
2013-03-15 |
2016-09-07 |
Durect Corp |
Zusammensetzungen mit rheologiemodifikator zur reduzierung der auflösungsvariabilität
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 d 방출 제형
|
MY183489A
(en)
|
2013-07-23 |
2021-02-22 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
AU2014298257B2
(en)
|
2013-08-02 |
2016-11-10 |
Macfarlan Smith Limited |
Process for the preparation of oxymorphone
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
AU2015207734B2
(en)
|
2014-01-15 |
2017-02-23 |
Rhodes Technologies |
Process for improved oxymorphone synthesis
|
US9932348B2
(en)
|
2014-01-15 |
2018-04-03 |
Rhodes Technologies |
Process for improved oxycodone synthesis
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
EP2937096B1
(de)
|
2014-04-23 |
2019-08-21 |
Julius-Maximilians-Universität Würzburg |
Aus RS1 abgeleitete Peptide, die Glukoseabsorption nach einer glukosereichen Mahlzeit herunterregulieren und die Insulinsensitivität steigern
|
RU2016147009A
(ru)
|
2014-05-01 |
2018-06-04 |
Сан Фармасьютикал Индастриз Лимитед |
Композиции с пролонгированным высвобождением в виде суспензии
|
US9962336B2
(en)
|
2014-05-01 |
2018-05-08 |
Sun Pharmaceutical Industries Limited |
Extended release suspension compositions
|
US10258583B2
(en)
|
2014-05-01 |
2019-04-16 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of guanfacine
|
US20180104197A9
(en)
*
|
2014-05-01 |
2018-04-19 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of metformin
|
EP3174515A4
(de)
|
2014-07-30 |
2018-03-21 |
Sun Pharmaceutical Industries Limited |
Verpackung mit zwei kammern
|
WO2016020508A2
(en)
|
2014-08-07 |
2016-02-11 |
Opko Ireland Global Holdings Ltd. |
Adjunctive therapy with 25-hydroxyvitamin d
|
US20170182070A1
(en)
|
2014-10-08 |
2017-06-29 |
Mayne Pharma International Pty Ltd. |
Controlled Release Doxycycline
|
US9849124B2
(en)
|
2014-10-17 |
2017-12-26 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
DE202015102279U1
(de)
|
2014-11-05 |
2015-08-14 |
Fresh Products, Inc. |
Urinalsieb
|
USD778411S1
(en)
|
2014-11-05 |
2017-02-07 |
Fresh Products, Inc. |
Urinal screen
|
USD778412S1
(en)
|
2014-11-10 |
2017-02-07 |
Fresh Products, Inc. |
Urinal screen
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
JP6857141B2
(ja)
|
2015-05-20 |
2021-04-14 |
ノバルティス アーゲー |
エベロリムスとダクトリシブとの薬学的組合せ
|
ES2925951T3
(es)
|
2015-07-22 |
2022-10-20 |
John Hsu |
Composición que comprende un agente terapéutico y un estimulante respiratorio y métodos para su uso
|
CA3018019A1
(en)
|
2016-03-28 |
2017-10-26 |
Opko Ireland Global Holdings, Limited |
Methods of vitamin d treatment
|
US10369078B2
(en)
|
2016-05-02 |
2019-08-06 |
Sun Pharmaceutical Industries Limited |
Dual-chamber pack for pharmaceutical compositions
|
US10238803B2
(en)
|
2016-05-02 |
2019-03-26 |
Sun Pharmaceutical Industries Limited |
Drug delivery device for pharmaceutical compositions
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
TW201825090A
(zh)
|
2016-11-23 |
2018-07-16 |
瑞士商諾華公司 |
增強免疫反應之方法
|
CA3084992A1
(en)
|
2017-12-20 |
2019-06-27 |
Fresh Products, Inc. |
Urinal screens
|
US10596165B2
(en)
|
2018-02-12 |
2020-03-24 |
resTORbio, Inc. |
Combination therapies
|
CN108958335B
(zh)
*
|
2018-07-27 |
2021-08-24 |
中国兵器工业第五九研究所 |
一种气候模块化数控贮存试验系统
|
USD925009S1
(en)
|
2018-10-25 |
2021-07-13 |
Fresh Products, Inc. |
Urinal screen
|
EP3965733A4
(de)
|
2019-05-07 |
2023-01-11 |
Clexio Biosciences Ltd. |
Esketamin enthaltende missbrauchssichere darreichungsformen
|
US20210315283A1
(en)
*
|
2020-04-13 |
2021-10-14 |
Aki, Inc. |
Disposable diffusing collar stay
|
JP2024505970A
(ja)
|
2021-02-02 |
2024-02-08 |
デュポン・ニュートリション・ユーエスエイ,インコーポレイテッド |
エチルセルロースを含有する水性ゲル組成物
|
CN115844854A
(zh)
*
|
2022-10-26 |
2023-03-28 |
沈阳药科大学 |
一种微囊型自悬浮茶碱缓释颗粒及其制备方法
|